Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors. 2010

Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
Nerviano Medical Sciences Srl, Business Unit Oncology, Viale Pasteur 10, 20014 Nerviano, MI, Italy. gabriella.traquandi@nervianoms.com

Abnormal proliferation mediated by disruption of the mechanisms that keep the cell cycle under control is a hallmark of virtually all cancer cells. Compounds targeting complexes between cyclin-dependent kinases (CDKs) and cyclins (Cy) and inhibiting their activity are regarded as promising antitumor agents to complement the existing therapies. An expansion of pyrazolo[4,3-h]quinazoline chemical class oriented to the development of three points of variability was undertaken leading to a series of compounds able to inhibit CDKs both in vitro and in vivo. Starting from the CDK selective but poorly soluble hit compound 1, we succeeded in obtaining several compounds showing enhanced inhibitory activity both on CDKs and on tumor cells and displaying improved physical properties and pharmacokinetic behavior. Our study led to the identification of compound 59 as a highly potent, orally bioavailable CDK inhibitor that exhibited significant in vivo efficacy on the A2780 ovarian carcinoma xenograft model. The demonstrated mechanisms of action of compound 59 on cancer cell lines and its ability to inhibit tumor growth in vivo render this compound very interesting as potential antineoplastic agent.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
November 2010, Bioorganic & medicinal chemistry letters,
Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
May 2023, Current medicinal chemistry,
Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
August 2011, Bioorganic & medicinal chemistry letters,
Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
September 2003, Bioorganic & medicinal chemistry letters,
Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
September 2010, International journal of molecular sciences,
Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
September 2018, European journal of medicinal chemistry,
Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
May 2010, Journal of medicinal chemistry,
Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
May 2011, Bioorganic & medicinal chemistry letters,
Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
November 2010, Bioorganic & medicinal chemistry letters,
Gabriella Traquandi, and Marina Ciomei, and Dario Ballinari, and Elena Casale, and Nicoletta Colombo, and Valter Croci, and Francesco Fiorentini, and Antonella Isacchi, and Antonio Longo, and Ciro Mercurio, and Achille Panzeri, and Wilma Pastori, and Paolo Pevarello, and Daniele Volpi, and Patrick Roussel, and Anna Vulpetti, and Maria Gabriella Brasca
September 2016, British journal of pharmacology,
Copied contents to your clipboard!